Cargando…
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation
Autores principales: | Iland, Harry J., Russell, Nigel, Dillon, Richard, Schuh, Andre C., Tedjaseputra, Aditya, Wei, Andrew, Khwaja, Asim, Knapper, Steven, Lane, Steven W., Reynolds, John, McMullin, Mary Frances, Martin, Annalise, Tan, Peter, Taussig, David C., Wong, Anny, Taper, John, Fraga, Christina, Kelly, Richard, Tawana, Kiran, Mehta, Priyanka, Mina, Alain, Altman, Jessica K., Mølle, Ingolf, Tauro, Sudhir, Tholouli, Eleni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250923/ https://www.ncbi.nlm.nih.gov/pubmed/36075018 http://dx.doi.org/10.1182/bloodadvances.2022007126 |
Ejemplares similares
-
Hyperleukocytosis in a neonate: A diagnostic dilemma
por: Sushanth,, et al.
Publicado: (2010) -
Progressive hyperleukocytosis is a relevant predictive marker for differentiation syndrome, early death, and subsequent relapse in acute promyelocytic leukemia
por: Yoon, Jae-Ho, et al.
Publicado: (2019) -
Paraneoplastic Hyperleukocytosis in Pancreatic Adenocarcinoma
por: Wu, Evan S., et al.
Publicado: (2017) -
Leukapheresis and Hyperleukocytosis, Past and Future
por: Zhang, Dongdong, et al.
Publicado: (2021) -
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
por: McCulloch, Derek, et al.
Publicado: (2017)